Due to the increasing prevalence of highly transmissible COVID-19 omicron subvariants, please ensure you are up to date on COVID vaccination. It is recommended that people get every vaccination for which they are eligible.*
- The CDC recommends that everyone ages 5 years and older get their primary series of COVID-19 vaccine, and everyone ages 12 years and older also receive a booster. Some people can receive two boosters.
- People who are moderately or severely immunocompromised have specific COVID-19 vaccine recommendations, including recommendations for a booster. Learn more about COVID-19 vaccine recommendations for people who are moderately or severely immunocompromised.
- Use the CDC’s COVID-19 booster tool to learn if and when you can get boosters to stay up to date with your COVID-19 vaccines.
- COVID-19 vaccine and booster recommendations may be updated as CDC continues to follow data related to vaccine effectiveness and safety, waning immunity and protection against variants.
If you get sick and test positive, do not wait. Call your primary care provider about prescribing Paxlovid. It must be started within five days of symptom onset.
*The current CMS mandate for health care workers requires only the initial vaccine series.
Children, 12 to 17 years, who test positive for COVID are eligible to receive an infusion if they have a qualifying comorbidity increasing the risk of a negative outcome.
Beginning Wednesday, May 18, the pediatric specialty infusion clinic will treat ambulatory patients. The process for referring patients from a UK HealthCare provider remains the same but the preferred COVID-19 monoclonal antibody combination is bebtelovimab. Supply is extremely limited and patients will be scheduled based on bebtelovimab availability.
Please note that this clinic is currently set up for COVID monoclonal antibody infusions only.
The Kentucky Children’s Hospital Specialty Infusion Clinic is located at the Kentucky Clinic, Floor 2, Wing D. Hours of operations are 3-9 p.m. Monday through Friday.
For more information, visit: Interim Guidance for the Outpatient Management of SARS-CoV-2 (COVID-19) with Monoclonal Antibody Therapy in Pediatric Patients or
Ilhem Messaoudi, PhD, UK chair of microbiology, immunology and molecular genetics, recently sat down to answer questions about SARS-CoV-2 – including what we know about the latest Omicron variants and what we might expect in the future. Read her interview on UKNow
UK Retail Pharmacies are now offering return-to-work COVID testing verification via telehealth. This service will be open to any UK HealthCare employees or HMO members.
Because it is a telehealth appointment, we will not be providing the COVID rapid test kit; however, anyone can order free COVID rapid test kits at https://www.covid.gov/tests.
How it works: Read more…
The UK HealthCare Pharmacy & Therapeutics Committee has approved the following updates and additions to interim guidance for adult and pediatric patients.
- Interim Guidance for the Use of Tixagevimab-Cilgavimab (Evusheld) in Adult Patients (4-19-22)
- Interim Guidance for the Use of Tixagevimab-Cilgavimab (Evusheld) in Pediatric Patients (4-22-22)
- Interim Pharmacotherapy Guidance for SARS-CoV-2 (COVID-19) Infection in Nonhospitalized Adult Patients (4-19-22)
- Interim Pharmacotherapy Guidance for SARS-CoV-2 (COVID-19) Infection in Hospitalized Adult Patients (updated 4-19-22)
- Interim Pharmacotherapy Guidance for the Inpatient Management of SARS-CoV-2 (COVID-19) Infection in Pediatric Patients (updated 4-27-22)
New and updated guidance is always available under the Clinical section of Guidelines and Documents linked from every page on this site.
“In this population-based study conducted in Sweden and Norway, vaccination against SARS-CoV-2 during pregnancy was not associated with an increased risk of adverse pregnancy outcomes.” – JAMA, March 24, 2022
As the impacts of COVID continue to evolve, Infection Prevention and Control (IPAC) and other operational teams have adjusted our Smart Return to Pre-COVID Operations table.
- We moved to Tier 2 on Wednesday, April 13 at 7 a.m.
- Tier criteria are based on CDC case county or positivity rate in Fayette County, as well as the number of COVID-positive patients in Chandler Hospital.
- At Tier 1, we can relax our requirement that all wear medical-grade masks, but given what we have learned about the benefits of masks in times of respiratory illness, IPAC may require universal masking or masking in close shared areas during those seasons regardless of COVID tier.
- For ongoing infection control purposes, we will continue to avoid shared food.
Questions about the updated tier guidance can be directed to Infection Prevention and Control (IPAC) or your leader.
A recording of Thursday’s update on our current Tier 2 operational status is now available on The Loop.